Pediatrics
Phase I/II
Children
Mol. targeted/Immunotherapy/Biologics
Atezolizumab,
Tiragolumab
Borinstein, Scott
International
Vanderbilt University
02-03-2023
Treatment
COGPEPN2121
Eligibility
Not Available
Not Available
Not Available